Arnold S. Leonard Cancer Research Fund

Quality of Life — Newer Concepts

The use of cold extracted pure fruit and herb botanic lipids for cancer patients on chemo and/or radiation therapy was stimulated by our cancer research program to genetically engineer an Interleukin 2 gene to a microbe. Lab studies demonstrated these cold extracted lipids to contain a full variety of phytosterols, essential fatty acids, omega 3 and omega 6, a great diversity of antioxidants including eight forms of Vitamin E tocopherols and tocotrienols, and dissolved minerals.

Over a seven year period we have collected clinical evidence using the same dietary supplement of cold extracted lipids that we used in our genetic engineering construct on quality of life in over 100 patients on chemo and radiation therapy.

The important question asked by oncologists and radiation therapists is do these substances affect tumor growth. Lab evidence also demonstrated most importantly that there was no tumor burden whatsoever when examined in two separate tumor models (metastatic adenocarcinoma to the liver and osteogenic sarcoma). Nor was there tumor reduction with these lipid substances or seed powders alone. (False claims are plentiful throughout the world on tumor reduction). We did see, however, synergy of these lipids with our genetic engineering in creating marked tumor reduction. Recent NMR studies confirmed the fact that the Immuno-Viva Core (black cumin and black raspberry lipids) contains a high level of thymoquinone, a compound that has been shown to stimulate prostaglandins E1, a modulator of the immune system. Since our genetic engineering construct is an immune stimulator, it seems reasonable that this synergy occurred. Although the lipids stimulated the immune response (natural killer and T8 cells) that increase was no where near the marked synergistic effect of our genetic engineering and the nutrient dense and diverse antioxidant lipids. Another important lab observation was the upregulation of seven anti-inflammatory genes, which may account for the low incidence of secondary infections in cancer patients. Collaborative research at the University of Maryland supported these anti-inflammatory observations. Also, a randomized human clinical study with these substances by the Berman Center for Clinical Studies demonstrated a decrease in CRP2, an indicator for inflammation.

The facts are that over 80% of patients had improvement in quality of life indicators. Instead of spending 10 -12 days with depression, anxiety, poor appetite, and susceptibility to infections, their lives, including energy, was improved after 3-4 days using the botanic lipid program.

With this evidence, we are interested in cooperating with large cancer therapy groups who are open minded enough to use these cold extracted nutrient dense and diverse super antioxidant lipids to promote quality of life in patients receiving chemo and radiation therapy.